Larvol Delta - Differential-disease-signatures-in-baricitinibtreated-alopecia-areata-patients-accentuate-persistent-Th1-inflammation-and-compensatory-cytotoxicIFN-effector-activity-in-nonresponders-versus-responders

Olumiant (baricitinib) - Eli Lilly

https://esdr2026.key4.live/programme-live-1?programType=list_v2&dtFormat=d%2Fm&embed=1&advSearchTypeList=21

Ilaria PICCINI‑GREBER

Sep 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next